---
name: ICBio
slug: icbiocro
site: cro
website_domain: icbiocro.com
summary: ICBio is a Bengaluru-based CRO offering bioavailability/bioequivalence studies, phase II–IV clinical trials, and LC-MS/MS bioanalysis. The excerpts cite regulatory approvals from DCGI-CDSCO, ANVISA, and EMA. Headquartered in Bengaluru, India.
tagline: Full-service CRO for BA/BE studies, clinical trials, bioanalysis and pharmacovigilance from Bengaluru, India
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: IN
tier2_domain_verified: false
updated_at: 2026-11-01T07:03:42.048Z
services_count: 14
modalities_count: 1
indications_count: 0
locations_count: 1
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# ICBio

Full-service CRO for BA/BE studies, clinical trials, bioanalysis and pharmacovigilance from Bengaluru, India

Listed on cro.directory.

## Summary

ICBio is a Bengaluru-based CRO offering bioavailability/bioequivalence studies, phase II–IV clinical trials, and LC-MS/MS bioanalysis. The excerpts cite regulatory approvals from DCGI-CDSCO, ANVISA, and EMA. Headquartered in Bengaluru, India.

## At a glance

- HQ country: IN

## Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Trial Services
- Clinical Operations
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Biostatistics & Statistical Programming
- Data Management & eClinical
- Medical Writing
- Pharmacovigilance & Drug Safety
- Regulatory Affairs
- Central Laboratory Services

## Modalities

- Small Molecule

## Locations

- Headquarters, Bengaluru, India

## Certifications

- ISO; Identifier: ISO 9001:2015; Source: https://icbiocro.com/about
- ISO; Identifier: ISO 15189:2012; Source: https://icbiocro.com/about
- ISO; Identifier: ISO 14001:2015; Source: https://icbiocro.com/about
- ISO/IEC; Identifier: ISO/IEC 27001:2013; Source: https://icbiocro.com/about
- OHSAS; Identifier: OHSAS 18001:2007; Source: https://icbiocro.com/about

## Long description

ICBio is a full-service Contract Research Organization headquartered in Bengaluru, India. It serves pharmaceutical and biopharmaceutical companies, and the excerpts also list herbal/nutraceutical, medical device, and cosmetics and personal care clients.

## Services

- Bioavailability and bioequivalence (BA/BE) studies, including PK studies in healthy volunteers and patient trials for generics and NCEs
- Clinical development services covering phases I–IV, with the excerpts describing phase II to IV support and phase 2 and 3 trials
- Bioanalytical research, with methods developed and validated for 200 molecules
- Biostatistics and statistical programming
- Regulatory services
- Pharmacovigilance, including ICSR, aggregate reports, signal and risk management, QPPV and PSMF support
- Medical writing and clinical data management
- Central laboratory services, described as integrated with LIMS

## Capabilities and infrastructure

- Clinical unit established in 2014, described as having 132 beds in one passage and 100 beds in another, with 24/7 doctor and paramedical coverage
- Bioanalytical laboratory with LC-MS/MS, including SCIEX and Shimadzu mass spectrometers and a PerkinElmer ICP-MS
- Facility of about 20,000 sq. ft. with access control and UPS backup
- Network of 150 sites across 17 cities, plus a large volunteer and patient database

## Quality and approvals

- The excerpts cite approvals from DCGI-CDSCO (India), ANVISA (Brazil), ISP (Chile), NPRA (Malaysia), MHRA, EMA, TGA, and several Middle East and African health authorities
- NABL and ILAC-MRA accreditation for the clinical laboratory, with GCLP compliance cited for the central lab
- ISO 9001:2015, ISO 15189:2012, ISO 14001:2015, ISO/IEC 27001:2013, and OHSAS 18001:2007 are listed
- The company states it follows ICH-GCP guidelines

## Track record

The excerpts cite over 16 years of experience, more than 90 clients, 1,000+ BA/BE studies, and about 500 phase trials, with work reaching over 56 countries.

## Related companies

- [Advanced Clinical](/companies/advancedclinical) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/advancedclinical/icbiocro)
- [Acromion Gmbh](/companies/acromion-gmbh) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/acromion-gmbh/icbiocro)
- [BioAgile Therapeutics](/companies/bioagiletherapeutics) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/bioagiletherapeutics/icbiocro)
- [Medidata Solutions](/companies/medidata-solutions) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/icbiocro/medidata-solutions)
- [Linical](/companies/linical) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/icbiocro/linical)
- [Veeda Lifesciences](/companies/veedalifesciences) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/icbiocro/veedalifesciences)
- [Krescent Medical Research](/companies/krescentmr) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/icbiocro/krescentmr)
- [PharPoint Research](/companies/pharpoint) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/icbiocro/pharpoint)

_Profile last updated: 2026-11-01T07:03:42.048Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.